NYTimes Letter to the Editor: Drug Shortages Continue to Vex

  • | by: Peter J. Pitts |
  • 02/10/2015 12:00 AM
N/A by N/A is licensed under N/A N/A

Re “Drug Shortages Continue to Vex Doctors” (news article, Feb. 11):
 
When it comes to addressing drug shortages, economic factors aren’t just “a contributing factor”; they’re the main factor.
 
Most of America’s drug shortages arise in the generics market, where profitability is fairly low. This market can sustain only a handful of manufacturers, so when supply disruptions occur, there aren’t a lot of additional producers (or in many cases any) in the market to pick up the slack.
 
Drugs that hold relatively stable prices, on the other hand, tend not to experience shortages, according to an October 2011 report by the Department of Health and Human Services. In other words, artificially low prices caused mainly by government programs — ranging from Medicaid to the problematic 340B discount drug program — have caused shortages. Where there’s still a profit, there are rarely shortages.
 
PETER J. PITTS

Washington, Feb. 11, 2014
 
The writer, a former associate commissioner of the Food and Drug Administration, is president of the Center for Medicine in the Public Interest.
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed

AARP's Stop Rx Greed Campaign Should Focus on AARP's Rx Greed

...  Read more

FDA is smashing the status quo for regulatory science

FDA is smashing the status quo for regulatory science

The most potent way the FDA can enable innovation is by being a partner in advancing new approaches to both drug developm...  Read more

True Cost of Socialized Medicine & the Right Way to Hold Down the Cost of Healthcare

True Cost of Socialized Medicine & the Right Way to Hold Down the Cost of Healthcare

...  Read more

DRUGWONKS BLOG